Neuroprotective activity of creatylglycine ethyl ester fumarate.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Stroke & Cerebrovascular Diseases

• Publication date

  2015-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jstrokecerebrovasdis.2014.10.005PMID 25561316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Amide Creatine Derivatives in Brain Hippocampal Slices, and Their Possible Usefulness for Curing Creatine Transporter Deficiency

  2013cited by this paper
• Drug Therapy in Stroke: From Preclinical to Clinical Studies

  2013cited by this paper
• Neuroprotective Effect of Phosphocreatine on Focal Cerebral Ischemia-Reperfusion Injury

  2012cited by this paper
• Guide for the Care and Use of Laboratory Animals (8th edn)

  2012cited by this paper
• Creatinyl amino acids—new hybrid compounds with neuroprotective activity

  2011cited by this paper
• Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

  2011cited by this paper
• Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

  2011cited by this paper
• [Amides of creatine: perspectives of neuroprotection].

  2011cited by this paper
• Effects of AMP-Activated Protein Kinase in Cerebral Ischemia

  2010cited by this paper
• The complexity of neurobiological processes in acute ischemic stroke.

  2009cited by this paper
• Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13

  2009cited by this paper
• An ion-pair reversed-phase HPLC method for determination of fresh tissue adenine nucleotides avoiding freeze-thaw degradation of ATP.

  2009cited by this paper
• Manual of Stroke Models in Rats

  2008cited by this paper
• Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases.

  2007cited by this paper
• Immunocytochemical detection of brain neurons using the selective marker NeuN

  2006cited by this paper
• Pharmacological Inhibition of AMP-activated Protein Kinase Provides Neuroprotection in Stroke*

  2005cited by this paper
• Glial Fibrillary Acidic Protein in Astrocytes in the Human Neocortex

  2005cited by this paper
• Glial fibrillary acidic protein in astrocytes in the human neocortex.

  2004cited by this paper
• Delayed neuronal death in the rat hippocampus following transient forebrain ischemia

  2004cited by this paper
• Optimization of cellular nucleotide extraction and sample preparation for nucleotide pool analyses using capillary electrophoresis.

  2003cited by this paper
• Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions.

  2003cited by this paper
• Ischemic cell death in brain neurons.

  1999cited by this paper
• Cerebral metabolic profile, selective neuron loss, and survival of acute and chronic hyperglycemic rats following cardiac arrest and resuscitation.

  1999cited by this paper
• Fatal protein — The story of CJD, BSE, and other prion diseases by R.M Ridley and H.F. Baker, pp 249. Oxford University Press, UK. 1998. £25 ISBN 0‐19‐852435‐8

  1999cited by this paper
• The alterations of brain lactate, lactate dehydrogenase, creatine phosphokinase and its influence on these of peripheral blood or liver tissue and entero-barrier during brain hypoperfusion

  1999cited by this paper
• Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

  1996cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Very Delayed Infarction after Mild Focal Cerebral Ischemia: A Role for Apoptosis?

  1996cited by this paper
• The Neuroprotective Effect of the Glycine Site Antagonist 3R-(+)-cis-4-Methyl-HA966 (L-687,414) in a Rat Model of Focal Ischaemia

  1995cited by this paper
• Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation.

  1995cited by this paper
• Introductory Biological Statistics

  1993cited by this paper
• Vibrodissociation of sliced mammalian nervous tissue.

  1991cited by this paper
• Reversible middle cerebral artery occlusion without craniectomy in rats.

  1989cited by this paper
• Experimental studies of ischemic brain edema

  1986cited by this paper
• Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.

  1986cited by this paper
• Conformationally restricted creatine analogues and substrate specificity of rabbit muscle creatine kinase.

  1980cited by this paper
• Determination of malonaldehyde precursor in tissues by thiobarbituric acid test.

  1978cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• The oxidation of glucose

  1969cited by this paper
• Creatine and creatine kinase measurement.

  1959cited by this paper

• Recent advances in the development of neuroprotective agents and therapeutic targets in the treatment of cerebral ischemia.

  2019cites this paper
• Neuroprotective effect of dimethyl fumarate in stroke: The role of nuclear factor erythroid 2-related factor 2

  2019cites this paper
• Therapeutic effects of oral dimethyl fumarate on stroke induced by middle cerebral artery occlusion: An animal experimental study

  2017cites this paper
• Creatine biosynthesis and transport in health and disease.

  2015cites this paper
• Prospects for the application of neun nuclear protein as a marker of the functional state of nerve cells in vertebrates

  2015cites this paper